Journals / Türkderm Türk deri hastalıkları ve frengi arşivi / 2020 / Cilt: 54 - Sayı: 1

Oral leukoplakia: Failure of topical imiquimod 5%

Oral lökoplaki: Topikal imiquimod %5’in başarısızlığı

Pages
32–33
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

LEBE, B., ÖZBAĞÇIVAN, Ö., İLKNUR, T., AKARSU, S., FETİL, E. (2022). Oral leukoplakia: Failure of topical imiquimod 5%. Türkderm Türk deri hastalıkları ve frengi arşivi, Cilt: 54 - Sayı: 1, 32–33. https://ajindex.com/articles/622492

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. Allam JP, Erdsach T, Wenghoefer M, Bieber T, Appel TR, Novak N: Successful treatment of extensive human papilloma virus-associated oral leucoplakia with imiquimod. Br J Dermatol 2008;158:644-6. de C Monteiro JS, de Oliveira SC, Reis Júnior JA, et al: Effects of imiquimod and low-intensity laser (λ660 nm) in chemically induced oral carcinomas in hamster buccal pouch mucosa. Lasers Med Sci 2013;28:1017-24.
  2. Gkoulioni V, Eleftheriadou A, Yiotakis I, et al: The efficacy of imiquimod on dysplastic lesions of the oral mucosa: An experimental model. Anticancer Res 2010;30:2891-6.
  3. Martinez-Lopez A, Blasco-Morente G, Perez-Lopez I, et al. Successful treatment of proliferative verrucous leukoplakia with 5% topical imiquimod. Dermatol Ther 2017:30. Lodi G, Franchini R, Warnakulasuriya S, et al: Interventions for treating oral leukoplakia to prevent oral cancer. Cochrane Database Syst Rev 2016;7:CD001829.